FCCM
MRNA icon

First City Capital Management’s Moderna MRNA Stock Holding History

First City Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-525
Closed -$205K – 171
2021
Q2 		$205K Buy
+525
New +$93.8K 0.11% 163

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

First City Capital Management's MRNA Position: Q3 2021 in Review

First City Capital Management sold out of Moderna (MRNA) in Q3 2021, closing a stake of 525 shares — an estimated $205K sold.

First City Capital Management first reported a position in MRNA in Q2 2021 and held it in 1 quarter. The position peaked at $205K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • First City Capital Management reported no remaining Moderna position as of Q3 2021 after selling out during the quarter.
  • First City Capital Management sold 525 Moderna shares in Q3 2021, an estimated $205K.
  • First City Capital Management first reported a position in Moderna in Q2 2021 and held it in 1 quarter.
  • First City Capital Management's Moderna position peaked at $205K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on First City Capital Management's 13F filing for Q3 2021, filed 28 Oct 2021.